Skip to content

Clinical trials

Observational Heart Failure trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Observational Country / region: China Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20125
20136
20145
20156
20169
20173
20184
20192
20202
20218
20226
202313
202413
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status37
Recruiting25
Completed22
Enrolling by invitation6
Not yet recruiting4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital6
Beijing Anzhen Hospital4
Nanjing Medical University4
Shanghai Zhongshan Hospital4
China National Center for Cardiovascular Diseases3
Chinese Academy of Medical Sciences, Fuwai Hospital3
Medtronic Cardiac Rhythm and Heart Failure3
Nanjing First Hospital, Nanjing Medical University3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Shanghai 10th People's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure97
Cardiovascular Diseases8
Atrial Fibrillation7
Arrhythmias, Cardiac6
Bradycardia4
Coronary Disease4
Heart Arrest4
Hypertension4
Hypertension, Pulmonary4
Shock, Cardiogenic4

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.